IPIC Message Board - Msg: 3912238

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: muddphudd who wrote (1137)	4/1/1998 7:24:00 AM
From: WeirdPro Randy	Read Replies (3) of 1359

<<What are the Harvard studies focused on?>> The Harvard study is the true study setup to evaluate the possible correlation of both Redux and phen-fen with heart valve problems. The study will evaluate a greater gamut of users, including those on longer duration therapies, and should probably enlight on further parameters of valvular disorder/disease. It is set up with 400 Redux, 400 phen-fen and 400 controls, and likely carries a great variance of users based on both dosages and durations. The study just released was the results of a halted study meant for the development of a once a day Redux tablet which was halted when the recall occurred. But since the patients were there, and still double-blinded, they restructured the study into an echocardiogram study on this patient population because it was already there. It was not intented to review the impact of short-term Redux use, it is just that short term usage of 77 days average was what they had when the study was halted.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next